Aaron Ciechanover
If packaging has a green dot, we know: This is waste for the yellow garbage can. Waste disposal in our cells works in a similar way. If a protein is no longer usable, a short piece of protein called "ubiquitin" is attached to it and it is disposed of. When the protein waste accumulates in the cells, tumors develop. Medicine can now respond individually to such errors in the molecular profile of patients, for example in diseases such as cancer and immune disorders. This medical progress raises a number of bioethical questions. The biochemist and Nobel Prize winner Aaron Ciechanover discusses the opportunities and bioethical issues of "personalized medicine" in a captivating way and shows how his research contributes to the development of new therapies.
Aaron Ciechanover, born in Haifa in 1947, is a professor at the medical faculty of the Technion - Israel Institute of Technology. Together with Avram Hershko and Irwin Rose, he was awarded the Nobel Prize in Chemistry in 2004 for his discovery of ubiquitin-controlled protein degradation.
Introduction: Prof. Dr. Frauke Melchior, molecular biologist and Rector of Heidelberg University
Language: English
Details:
Date: 30.11.2024
Time: 20:00
Type:
Medicine made to measure
Event type:
Geist Heidelberg Lecture
Prices plus fees
Regular 15,90 €
Reduced 12,90 €
Member 9,90 €
The lecture by Nobel Prize winner Aaron Ciechanover has unfortunately been canceled due to the situation in Israel and the associated travel problems.
